← Back to directory

Marianne Paesmans

Researcher Next ID · RN-039699

Researcher · Biochemistry, Genetics and Molecular Biology

Université Libre de Bruxelles

Brussels, Belgium

Accepting doctoral researchersFunding unknown
Works count
677
Citation count
18,685
H-index
66
i10-index
222

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Breast Cancer Treatment Studies
Lung Cancer Diagnosis and Treatment
Neutropenia and Cancer Infections

Publications

  • Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer

    JCI Insight · 2019 · https://doi.org/10.1172/jci.insight.129641

  • Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta‐analysis

    The Laryngoscope · 2018 · https://doi.org/10.1002/lary.27591

  • Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status

    JNCI Journal of the National Cancer Institute · 2017 · https://doi.org/10.1093/jnci/djx206

  • Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx730

  • Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study

    Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.44.2285

  • Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

    Annals of Oncology · 2011 · https://doi.org/10.1093/annonc/mdr352

  • Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project

    Journal of Thoracic Oncology · 2010 · https://doi.org/10.1097/jto.0b013e3181d0a4f5

  • Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.28.5643

  • Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

    Journal of Thoracic Oncology · 2008 · https://doi.org/10.1097/jto.0b013e31815e6d6b

  • Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

    British Journal of Cancer · 2007 · https://doi.org/10.1038/sj.bjc.6603756

  • Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk196

  • Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients Using a Score Predictive for Complications

    Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.9909

  • Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature

    Lung Cancer · 2005 · https://doi.org/10.1016/j.lungcan.2005.01.002

  • The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

    British Journal of Cancer · 2004 · https://doi.org/10.1038/sj.bjc.6602258

  • HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.

    PubMed · 2002

  • Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

    Annals of Oncology · 2002 · https://doi.org/10.1093/annonc/mdf252

  • Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

    European Respiratory Journal · 2001 · https://doi.org/10.1183/09031936.01.00062201

  • Prognostic factors for patients with small cell lung carcinoma

    Cancer · 2000 · https://doi.org/10.1002/1097-0142(20000801)89:3<523::aid-cncr7>3.0.co;2-6

  • The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

    Journal of Clinical Oncology · 2000 · https://doi.org/10.1200/jco.2000.18.16.3038

  • A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

    Lung Cancer · 2000 · https://doi.org/10.1016/s0169-5002(00)00127-6

  • A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis

    Supportive Care in Cancer · 2000 · https://doi.org/10.1007/s005200050284

  • Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

    New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199907293410502

  • Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program

    Antimicrobial Agents and Chemotherapy · 1996 · https://doi.org/10.1128/aac.40.5.1108

  • Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

    Antimicrobial Agents and Chemotherapy · 1995 · https://doi.org/10.1128/aac.39.2.445

  • Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

    Journal of Clinical Oncology · 1995 · https://doi.org/10.1200/jco.1995.13.5.1221

Current projects

    No projects listed.